NCT01878006View on ClinicalTrials.gov

Genetic Effects on Dopamine Response to an Opiate

PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

June 13, 2013

Primary Completion Date

April 27, 2017

Study Completion Date

April 27, 2017

Conditions
Polymorphism-GeneticPainAddiction
Interventions
DRUG

Morphine

DRUG

Placebo

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

NCT01878006 - Genetic Effects on Dopamine Response to an Opiate | Biotech Hunter | Biotech Hunter